NORTHERN TRUST CORP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q2 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$2,485,248
+34.0%
177,391
-1.0%
0.00%
Q2 2023$1,854,544
+835.4%
179,183
+735.0%
0.00%
Q1 2023$198,272
+2.4%
21,458
-1.7%
0.00%
Q4 2022$193,552
+5.8%
21,821
-0.8%
0.00%
Q3 2022$183,000
+6.4%
21,998
+4.8%
0.00%
Q2 2022$172,000
-87.7%
20,990
-87.0%
0.00%
Q1 2022$1,401,000
-13.0%
160,880
-5.0%
0.00%
Q4 2021$1,611,000
-43.0%
169,301
+0.8%
0.00%
-100.0%
Q3 2021$2,826,000
-6.4%
168,024
-14.9%
0.00%0.0%
Q2 2021$3,018,000
-25.3%
197,554
-4.7%
0.00%0.0%
Q1 2021$4,039,000
-6.4%
207,296
-13.4%
0.00%0.0%
Q4 2020$4,314,000
-9.1%
239,380
-2.7%
0.00%0.0%
Q3 2020$4,745,000
-8.1%
245,963
+24.4%
0.00%0.0%
Q2 2020$5,165,000
+25.9%
197,719
-14.0%
0.00%0.0%
Q1 2020$4,104,000
-46.0%
230,027
+1.0%
0.00%
-50.0%
Q4 2019$7,600,000
+42.6%
227,763
+1.8%
0.00%
+100.0%
Q3 2019$5,331,000
+168.2%
223,707
+304.3%
0.00%
Q2 2019$1,988,000
+105.4%
55,336
+111.3%
0.00%
Q1 2019$968,000
+27.7%
26,194
+48.8%
0.00%
Q4 2018$758,000
+0.3%
17,598
+10.0%
0.00%
Q3 2018$756,000
+11.7%
15,998
+17.6%
0.00%
Q2 2018$677,00013,5980.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2020
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders